Dynavax Technologies (DVAX) halted ahead of FDA adcom
- Top 10 News for 9/8 - 9/12: Apple's Main Event; Boeing Inks Mega Deal; Routed RadioShack (Slightly) Recovers
- Apple (AAPL) Reports Record Pre-Orders for iPhone 6
- Darden Restaurants (DRI) Reports In-Line Q1 EPS; Guides Q2 EPS to Strong Side
- Unusual 11 Mid-Day Movers 9/12: (NETE) (CNVR) (VNET) Higher; (AMRN) (RSH) (RCPI) Lower
- Alibaba (BABA) Plans Closing Books Early After IPO Covered (YHOO)
Dynavax Technologies Corporation (NASDAQ: DVAX) halted ahead of FDA adcom
You May Also Be Interested In
- Medivation (MDVN) Xtandi Efficacy Supplement Posted on FDA Website; Label Adds Chemotherapy-Naive mCRPC Study
- NPS Pharmaceuticals (NPSP) Comments on Trading Halt; FDA Panel to Review Natpara BLA
- Orexigen Therapeutics (OREX) Falls 9% Despite FDA Approval
Create E-mail Alert Related CategoriesFDA, Trader Talk, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!